Zenas: Differentiated B-Cell Targeting Drug With Q3 Of 2025 Catalyst
Zenas BioPharma, Inc.'s obexelimab's potential in treating autoimmune diseases and upcoming phase 2 & 3 trial results. Read ...
Medical Dialogues11h
Study Highlights Ultrasonic Viscoelastic Imaging as a Noninvasive Tool for Identifying Proliferative Lupus Nephritis
China: A recent study highlights the potential of ultrasonic viscoelastic imaging as a noninvasive tool for evaluating ...
Lupus Foundation of America13h
Novel Stromal Cell Study in Lupus Reaches Critical Milestone
The Lupus Foundation of America (LFA) is excited to share that enrollment for the MiSLE (Mesenchymal Stromal Cells in Systemic Lupus Erythematosus) study was officially completed on February 21, 2025 ...
Canadian Medical Association Journal14h
Painful feet as the presenting symptom of mononeuritis multiplex in a 47-year-old woman with systemic lupus erythematosus
Key points A 47-year-old French-speaking woman of African descent presented to the emergency department with a 1-week history of severe foot pain and difficulty walking. For the preceding 2 months she ...